Covetrus Inc
F:2NJ
Relative Value
There is not enough data to reliably calculate the relative value of 2NJ.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
2NJ Competitors Multiples
Covetrus Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
C
|
Covetrus Inc
F:2NJ
|
3B EUR | 0.8 | -272.6 | 26.9 | -4 440.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
121.1B USD | 0.3 | 27.9 | 19.6 | 22 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
72.5B USD | 0.2 | 44.6 | 15.6 | 19.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
72B USD | 0.2 | 44.4 | 15.5 | 19.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53B USD | 0.2 | 31.9 | 15.3 | 19.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 2.8 | 35.5 | 26.3 | 26.3 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD | 0.7 | 23.2 | 11.3 | 15.9 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.1B CNY | 0.2 | 11.2 | 15.1 | 15.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.1B CNY | 1.4 | 16 | 12.3 | 12.3 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.7B HKD | 0.1 | 8.3 | 1.5 | 1.9 |